p21 and CD166 as predictive markers of poor response and outcome after fluorouracil-based chemoradiotherapy for the patients with rectal cancer

BACKGROUND: Pre-operative chemoradiotherapy (CRT) is the standard treatment in clinical stage T3/4 or node positive rectal cancer. However, there are no established biomarkers that can predict the pathological response and clinical outcome to CRT. METHODS: Immunohistochemical staining was performed...

Descripción completa

Detalles Bibliográficos
Autores principales: Sim, Sung Hoon, Kang, Mi-Hyun, Kim, Yu Jung, Lee, Keun-Wook, Kim, Duck-Woo, Kang, Sung-Bum, Eom, Keun-Yong, Kim, Jae-Sung, Lee, Hye Seung, Kim, Jee Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101833/
https://www.ncbi.nlm.nih.gov/pubmed/24708484
http://dx.doi.org/10.1186/1471-2407-14-241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101833/
https://www.ncbi.nlm.nih.gov/pubmed/24708484
http://dx.doi.org/10.1186/1471-2407-14-241

Ejemplares similares